Literature DB >> 6611266

In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen)

R Mandeville, S S Ghali, J P Chausseau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6611266     DOI： 10.1016/0277-5379(84)90174-3

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  7 in total

1.  Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.

Authors:  Yoshihiro Suzuki; Norio Aoyama; Junji Minamide; Ken Takata; Takashi Ogata
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

2.  The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro.

Authors:  T Paavonen; L C Andersson
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

3.  Influence of adjuvant tamoxifen on blood lymphocytes.

Authors:  S Rotstein; H Blomgren; B Petrini; J Wasserman; L V von Stedingk
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

4.  Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells.

Authors:  Y K Hoh; E H Lim; S O Ooi; O L Kon
Journal:  Experientia       Date:  1990-10-15

5.  Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.

Authors:  J Lukac; Z Kusić; D Kordić; M Koncar; A Bolanca
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene.

Authors:  R Valavaara; J Tuominen; A Toivanen
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets.

Authors:  Pei-Chen Yu; Chen-Hao Huang; Chih-Jung Kuo; Po-Huang Liang; Lily Hui-Ching Wang; Max Yu-Chen Pan; Sui-Yuan Chang; Tai-Ling Chao; Si-Man Ieong; Jun-Tung Fang; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.